United Therapeutics Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$748,900	$714,900	$677,700	$614,700
Gross Profit	665,800	637,100	604,800	543,700
EBITDA	417,800	338,600	426,900	324,200
EBIT	398,700	319,900	411,900	310,500
Net Income	309,100	278,100	306,600	217,100
Net Change In Cash	748,900	714,900	677,700	614,700
Free Cash Flow	300,700	187,100	338,300	72,000
Cash	1,553,900	1,355,700	1,251,500	1,207,700
Basic Shares	48,400	47,500	49,700	49,800

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$2,327,500	$1,936,300	$1,685,500	$1,483,300
Gross Profit	2,070,000	1,789,600	1,563,000	1,375,200
EBITDA	1,386,800	1,040,300	736,800	646,300
EBIT	1,333,600	989,000	686,900	596,400
Net Income	984,800	727,300	475,800	514,800
Net Change In Cash	2,327,500	1,936,300	1,685,500	1,483,300
Cost of Revenue		66,400	156,100	300
Free Cash Flow	747,600	663,700	477,400	696,400
Cash	1,207,700	961,200	894,800	738,700
Basic Shares	49,700	48,500	47,300	44,600